WUXI PHARMATECH (NY:WX)
15.04
0.11 (0.73%)
| WUXI PHARMATECH (NY:WX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $15.15 | 52 Week High | $15.82 | ||
| Open | $14.99 | 52 Week Low | $3.67 | ||
| Day High | $15.21 | P/E | N/A | ||
| Day Low | $14.84 | EPS | $0.00 | ||
| Volume | 383,271 | ||||
| More WX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CLWR | 4 | BOBE | 3 |
| GU | 3 | VISN | 3 |
| JASO | 3 | BBI | 3 |
| SSRX | 3 | TBAC | 3 |
| AWK | 2 | CLWR | 2 |
| VISN | 2 | ZLC | 2 |
Entities who have mentioned WX
- Jefferies & Co | View Related Stories »
- Trading Radar | View Related Stories »
- UBS | View Related Stories »
- Standard & Poor's | View Related Stories »
- After-Hours Movers | View Related Stories »
- Banc of America | View Related Stories »
- Piper Jaffray | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Citi | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Lehman Brothers | View Related Stories »
- Robert W Baird | View Related Stories »
- Warburg Pincus | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Morgan Stanley | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- New Home Sales | View Related Stories »
- Credit Suisse | View Related Stories »
- Crude Oil | View Related Stories »
- Dividend | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Goldman Sachs | View Related Stories »
- Stifel Nicolaus | View Related Stories »
- JPMorgan | View Related Stories »
View All Major News StreetInsider.com Major News for WX
- WuXi PharmaTech (WX) Posts Q3 non-GAAP EPS of $0.24, Tops by 9c
- WuXi PharmaTech (WX) Reports Q2 Non-GAAP EPS of $0.24, Beats by 12c; Affirms FY09 Sales Outlook
- WuXi PharmaTech (WX) Reports Q1 Adj-EPS of $0.20; Affirms FY09 Outlook
View All ReportsStreetInsider.com Reports on WX
- WuXi PharmaTech (WX) Posts Q3 non-GAAP EPS of $0.24, Tops by 9c
- Trading Radar for 11/17: Home Depot (HD), Saks (SKS), Target (TGT), Autodesk (ADSK), La-Z-Boy (LZB) Report
- Credit Suisse Downgrades WuXi PharmaTech (WX) to Neutral
- Goldman Sachs Starts WuXi PharmaTech (WX) at Buy, Adds to Conviction Buy List
- Notable Analyst Rating Changes 8/13: HD, CCE, WX, TXN Upgraded; LOW, NOK, SOL, JASO, PALM, XTO Downgraded
View All Press ReleasesCompany Press Releases on WX
- WuXi PharmaTech Announces Third-Quarter 2009 Results
- WuXi AppTec Receives 2009 Schering-Plough Excellence Award
- WuXi PharmaTech Schedules Third-Quarter 2009 Earnings Release
- WuXi PharmaTech Appoints Dr. Hui Cai as Vice President of Business Development
- StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc.
StreetInsider Reports on WX by Category
View All BlogsBlogs on WX
- China Biotech Week in Review: CROs Consolidating
- WuXi Pharma Feels the Worst of the Downturn Is Over
- Analyst upgrades, downgrades and initiations: DLTR, JCP, JWN, LEA, RIMM, S ...
- WuXi Pharma Planning New Facility for R&D Services
- The Complete List of Chinese ADR Stocks
Comments on WX
No comments are currently available.
